Cross‐tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease
Apolipoprotein E (APOE) ε4 is the strongest genetic risk factor for late‐onset Alzheimer's disease (AD), but its contribution to disease pathogenesis remains incompletely understood.